Big Pharma Tries to Monopolize CBD Oil Market

Story at-a-glance-

• The cannabinoids in cannabis — cannabidiol (CBD) and tetrahydrocannabinol (THC) — work by way of naturally occurring cannabinoid receptors embedded in cell membranes throughout your body
• The fact that your body is replete with cannabinoid receptors, key to so many biological functions, is why there's such enormous medical potential for cannabis
• South Dakota has rescheduled CBD from a Schedule I to a Schedule IV substance by excluding it from the definition of marijuana
• GW Pharmaceuticals failed in its efforts to restrict Schedule IV classification to FDA approved CBD products only, which prevented the company from creating a monopoly in South Dakota
• The legal status of CBD oil as a nutritional supplement is now threatened by drug companies seeking FDA approval for CBD-containing drugs

https://articles.mercola.com/sites/articles/archive/2017/12/11/big-pharma-tries-to-monopolize-cbd.aspx